|
(HealthNewsDigest.com) – Chicago, IL, – Recently, measurement of very low concentrations of C-reactive protein (CRP) has gained popularity as a potential new means for predicting the risk of future cardiac complications. A slew of research over the past two decades has spawned interest in the use of the blood concentration of CRP for predicting a first coronary event.
This application has been made possible with the development of high-sensitivity CRP (hsCRP) assays that can measure the typically low concentrations of CRP that may suggest impending cardiac dysfunction. On the afternoon of Wednesday, July 22, Gary Myers, PhD, from the U.S. Centers for Disease Control and Prevention, will look at findings on this relationship in a presentation titled “CRP and Lp-PLA2 as Markers of Cardiovascular Disease and Stroke.” This lecture will take place in the course of an impressive daylong Chair’s Invited Session titled “Beyond Lipids – Lipoproteins and Inflammatory Markers for Cardiovascular Risk Assessment” (session 64301).
Inflammation is pivotal in all phases of atherosclerosis. Among the numerous inflammatory biomarkers, the largest amount of published data supports a role for CRP as a robust and independent risk marker in the prediction of primary and secondary adverse cardiovascular events. In addition to being a risk marker, there is significant evidence indicating that CRP may indeed participate in atherogenesis.
In fact, a committee of the National Committee of Clinical Biochemistry chaired by Dr. Myers concluded a recent guideline on emerging cardiac markers saying, “Based on a thorough review of the published literature, only hsCRP met all of the stated criteria required for acceptance as a biomarker for [cardiac] risk assessment in primary prevention.” Dr. Myers will also be joining a number of his NACB colleagues in a July 21 full-day symposium that examines the question, “What Is the Evidence for Utilization of Cardiac Markers?”
For instructions on receiving a complimentary press registration, contact Sue Parham in the AACC Press Office in Room N427B/C of the McCormick Place Convention Center, Chicago, IL (additional contact information is at top of page)
AACC, based in Washington, DC, is a leading professional society dedicated to improving healthcare through laboratory medicine. Its over 9,000 members are clinical laboratory professionals, physicians, research scientists, and others involved in developing tests and directing laboratory operations. AACC brings this community together with programs that advance knowledge, expertise, and innovation. AACC’s Annual Meeting, which attracts around 20,000 delegates, is the world’s largest conference on laboratory medicine and technology
Subscribe to our FREE Ezine and be eligible for Health News, discounted products/services and coupons related to your Health. We publish 24/7.
HealthNewsDigest.com